KBI Biopharma is headed to Seoul, Korea for KoNECT 2024 this October!
Meet with the KBI Biopharma Team:
KBI Biopharma is a leading global contract development and manufacturing organization (CDMO) providing fully integrated, accelerated drug development and biologics manufacturing services and expertise to life science companies. With each of our 500+ client partners, we work closely to personalize and accelerate drug development programs. Built upon a foundation of world-class analytics capabilities and extensive scientific and technical expertise, we deliver robust process development and clinical and commercial cGMP manufacturing services for mammalian, microbial, and cell therapy programs. Recognized for quality manufacturing, we help clients advance drug candidates into the clinic and beyond.
Learn more about KBI Biopharma >>
KoNECT, co-hosted by Ministry of Health and Welfare and Ministry of Food and Drug Safety, brings together attendees from across government, academia and industry to share up-to-date topics on clinical trials and development.